It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
SAO PAULO/FRANKFURT (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”
AstraZeneca declined to comment immediately.
A source familiar with the matter told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.
“Everything is proceeding as expected, without any record of serious vaccine-related complications involving any of the participating volunteers,” the Brazilian university said in a statement.
South Korean authorities have sought to reassure people as the number who have died after being vaccinated against seasonal influenza rose to 13. The doctor leading an inquiry into the deaths has said he does not believe the vaccine and fatalities are connected
originally posted by: dug88
Hey, remember that company AstraZeneca? One of those ones working on vaccine trials that were recently
made exempt from any liability for any damages they cause.
The safety of their trials was also recently questioned and put on hold after some issues.
Well they weren't about to let a little thing like health and safety get in the way as they continued their trials in Brazil where a volunteer has now died.
www.reuters.com...
SAO PAULO/FRANKFURT (Reuters) - Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue.
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”
AstraZeneca declined to comment immediately.
A source familiar with the matter told Reuters the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the person was part of the control group that was given a meningitis jab.
“Everything is proceeding as expected, without any record of serious vaccine-related complications involving any of the participating volunteers,” the Brazilian university said in a statement.
Don't worry though, as they say, 'Everything's proceeding as expected.' And it's fine because it was a volunteer given a control dose of meningitis vaccine that died. Nothing to see here folks the global experiment shall continue as planned. Lives lost be damned. Can't make an omelette without breaking a few eggs and all that.
originally posted by: dug88
a reply to: Vasa Croe
People on ATS too lazy to even read a provided link. As it is I already quoted more than ats allows.
CNN Brasil reported that the volunteer was a 28-year-old man who lived in Rio de Janeiro and died from COVID-19 complications.
originally posted by: dug88
a reply to: BelowLowAnnouncement
The placebo was a dose of the meningitis vaccine. It was in my op. Typically, vaccines with known dangerous side-effects are not used as placebos in medical trials.